JONA PHARMA
ActiveJONA PHARMA has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €21k and a net result of €15. Equity remains stable across the filed fiscal years (±1.3% per year). Its solvency ranks better than 27% of 9623 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.9% (low).
Checked score
Score 2024
48
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability38=
Solvency44▲+1
Growth52=
Track record100
Bankruptcy probability, 12 months
0.9%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €1k at 30 days only on tighter terms
Liquidity ample (current ratio 1.71 against 1.69 in 2023; short-term debt: 58.6% and cash: 1.9% of total assets), but 80.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
19.1%
Return on assets
0%
Age of the figures
21 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 17-04-2026, 260 days past the deadline. Measured on financial year 2023: companies more than 90 days late are in an abnormal legal state today in 5.61% of cases, against 1.66% across all filers.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
260 d late
2023
153 d late
2022
108 d late
2021
79 d late
2020
152 d late
2019
517 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, abbreviated schema
Equity
€21k▲ 0.1%
2023 · €21k
2018: €11k
2019: €11k
2020: €21k
2021: €21k
2022: €21k
2023: €21k
2018 → 2024
Total assets
€112k▼ 5.6%
2023 · €119k
2018: €28k
2019: €63k
2020: €96k
2021: €132k
2022: €114k
2023: €119k
2018 → 2024
Net result
€15▲ 60.8%
2023 · €10
2018: €53
2019: €8
2020: €10k
2021: €269
2022: €149
2023: €10
2018 → 2024
Working capital
€46k▼ 4.4%
2023 · €49k
2018: €24k
2019: €-1k
2020: €13k
2021: €43k
2022: €47k
2023: €49k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€21k-€21k▲ 1.3%€21k▲ 0.7%€21k=€21k▲ 0.1%
Operating result€11k-€4k▼ 66.8%€2k▼ 49.0%€2k▼ 5.5%€930▼ 45.1%
Net result€10k-€269▼ 97.3%€149▼ 44.5%€10▼ 93.6%€15▲ 60.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen four years in a row; 2024 is 45% below 2023 and is the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Equity and liabilities €112k
Equity
€21k▲ 0.1%
Debt
€91k▼ 6.8%
The debt ratio falls from 82.0% to 80.9%. Equity is higher and debt is lower.
Key figures and ratios
Solvency
19.1%▲
2023 · 18.0%
Current ratio
1.71▲
2023 · 1.69
Quick ratio
1.71▲
2023 · 1.69
Debt / equity
4.24▼
2023 · 4.55
ROE
0.1%▲
2023 · 0.0%
ROA
0.0%▲
2023 · 0.0%
Debt
€91k▼
2023 · €97k
Debt ≤ 1 year
€66k▼
2023 · €70k
Debt > 1 year
€25k=
2023 · €25k
Income taxes
€294▼
2023 · €475
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€119k€112k▼
Current assets29/58€119k€112k▼
Amounts receivable within one year40/41€115k€110k▼
Trade receivables40€8k€4k▼
Other amounts receivable41€107k€106k▼
Cash at bank and in hand54/58€4k€2k▼
Deferred charges and accrued income490/1-€212
Equity and liabilities
Total equity and liabilities10/49€119k€112k▼
Equity10/15€21k€21k▲
Contributions10/11€6k€6k=
Reserves13€15k€15k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€13k€13k▲
Amounts payable17/49€97k€91k▼
Amounts payable after more than one year17€25k€25k=
Financial debts170/4€25k€25k=
Amounts payable within one year42/48€70k€66k▼
Trade debts44€8k€3k▼
Suppliers440/4€8k€3k▼
Advances received on contracts in progress46€610-
Taxes, remuneration and social security45€1k€1k▼
Taxes450/3€1k€1k▼
Other amounts payable47/48€60k€61k▲
Accrued charges and deferred income492/3€2k€17▼
Income statement
Code20232024
Other operating charges640/8€722€835▲
Gross operating margin9900€2k€2k▼
Operating profit (loss)9901€2k€930▼
Financial income75/76B€0€1k▲
Recurring financial income75€0€1k▲
Financial charges65/66B€1k€2k▲
Recurring financial charges65€1k€2k▲
Profit (loss) for the period before taxes9903€485€309▼
Income taxes67/77€475€294▼
Profit (loss) for the period9904€10€15▲
Profit (loss) for the period to be appropriated9905€10€15▲
Appropriation of the result
Profit (loss) to be appropriated9906€10€15▲
Transfer to equity691/2€10€15▲
To other reserves6921€10€15▲
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
17-04
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 260 days late
2024
31-12
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 153 days late
2023
16-11
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 108 days late
2022
18-10
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 79 days late
2021
30-12
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 152 days late
30-12
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 517 days late
2020
31-12
Financial
Highest result since 2018net €10k ▲120375%
Operating result €11k, net result €10k, both a record.
2019
31-12
Financial
Weakest financial yearnet €8 ▼84.3%
Net result drops to €8, the lowest in the series; recovery starts the following year.
30-09
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 61 days late
2018
28-09
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 59 days late
2017
16-10
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 77 days late
07-03
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema · 219 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Temse · 1 establishment unit since 2012
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Dorpstraat 619140 TemseGround area
1,144 m²
Building footprint
223 m²
Volume, LiDAR
1,449 m³
Parcel 46008A0689/00B000, Flanders · tallest building 12.1 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
JONA PHARMA
since 20122.210.958.909
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46008A0689/00B000 | Flanders | 1,144 m² | 1 · 222 m² | 12.1 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteTemse2.210.958.909
Similar companies · same sector, comparable size
Rêve de Chocolat
BE 0804.008.155
Aarschot · Eq €21k
LEANDRO
BE 0765.499.056
Zonhoven · Eq €21k
HISOYE SORO
BE 0751.536.303
Sint-Truiden · Eq €22k
FBT - SIX
BE 0746.784.687
Mons · Eq €21k
DESIGN 4 FOODSERVICE
BE 0808.714.338
Heusden-Zolder · Eq €22k
Of 2,477 companies in sector 47279 we hold annual accounts for 950. 706 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company (pre-2019)
Founded01-06-2012
Fiscal year end31-12
Activities, NACEBEL
47279Other retail sale of food
47750Retail sale of cosmetics and toilet articles
70200Business and other management consultancy
Sources
Crossroads Bank for EnterprisesNational Bank · 12 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.